Ghrelin interacts with human plasma lipoproteins

被引:91
作者
De Vriese, Carine
Hacquebard, Mirjam
Gregoire, Francoise
Carpentier, Yvon
Delporte, Christine
机构
[1] Univ Libre Bruxelles, Dept Biochem & Nutr, Fac Med, B-1070 Brussels, Belgium
[2] Univ Libre Bruxelles, L Deloyers Lab Expt Surg, Fac Med, B-1070 Brussels, Belgium
关键词
D O I
10.1210/en.2006-1281
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ghrelin, a peptide hormone produced predominantly by the stomach, stimulates food intake and GH secretion. The Ser(3) residue of ghrelin is mainly modified by a n-octanoic acid. In the human bloodstream, ghrelin circulates in two forms: octanoylated and desacylated. We previously demonstrated that ghrelin is desoctanoylated in human serum by butyrylcholinesterase (EC 3.1.1.8) and other esterase(s), whereas in rat serum, only carboxylesterase ( EC 3.1.1.1) is involved. The aims of this study were to determine the role of lipoprotein-associated enzymes in ghrelin desoctanoylation and the role of lipoproteins in the transport of circulating ghrelin. Our results show that ghrelin desoctanoylation mostly occurred in contact with low-density lipoproteins (LDLs) and lipoprotein-poor plasma subfractions. Butyrylcholinesterase and platelet-activating factor acetylhydrolase (EC 3.1.1.47) were responsible for the ghrelin hydrolytic activity of the lipoprotein-poor plasma and LDL subfractions, respectively. Moreover, we observed that ghrelin is associated with triglyceride-rich lipoproteins (TRLs), high-density lipoproteins (HDLs), very high-density lipoproteins (VHDLs), and to some extent LDLs. In conclusion, we report that the presence of the acyl group is necessary for ghrelin interaction with TRLs and LDLs but not HDLs and VHDLs. Ghrelin interacts via its N- and C-terminal parts with HDLs and VHDLs. This suggests that, whereas TRLs mostly transport acylated ghrelin, HDLs and VHDLs transport both ghrelin and des-acyl ghrelin.
引用
收藏
页码:2355 / 2362
页数:8
相关论文
共 46 条
  • [11] Ghrelin degradation by serum and tissue homogenates: Identification of the cleavage sites
    De Vriese, C
    Gregoire, F
    Lema-Kisoka, R
    Waelbroeck, M
    Robberecht, P
    Delporte, C
    [J]. ENDOCRINOLOGY, 2004, 145 (11) : 4997 - 5005
  • [12] COMPARISON OF DIFFERENT SANDWICH ENZYME IMMUNOASSAYS FOR THE QUANTITATION OF HUMAN APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-A-II
    DUBOIS, DY
    CANTRAINE, F
    MALMENDIER, CL
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1987, 96 (01) : 115 - 120
  • [13] DUBOISPRESLE N, 1995, MOL PHARMACOL, V47, P647
  • [14] A NEW AND RAPID COLORIMETRIC DETERMINATION OF ACETYLCHOLINESTERASE ACTIVITY
    ELLMAN, GL
    COURTNEY, KD
    ANDRES, V
    FEATHERSTONE, RM
    [J]. BIOCHEMICAL PHARMACOLOGY, 1961, 7 (02) : 88 - &
  • [15] FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0
  • [16] Development of high affinity selective VIP1 receptor agonists
    Gourlet, P
    Vandermeers, A
    Vertongen, P
    Rathe, J
    De Neef, P
    Cnudde, J
    Waelbroeck, M
    Robberecht, P
    [J]. PEPTIDES, 1997, 18 (10) : 1539 - 1545
  • [17] Guerra R, 1997, J LIPID RES, V38, P2281
  • [18] DRUG-BINDING IN PLASMA - A SUMMARY OF RECENT TRENDS IN THE STUDY OF DRUG AND HORMONE-BINDING
    HERVE, F
    URIEN, S
    ALBENGRES, E
    DUCHE, JC
    TILLEMENT, JP
    [J]. CLINICAL PHARMACOKINETICS, 1994, 26 (01) : 44 - 58
  • [19] Purification and characterization of rat des-Gln14-ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor
    Hosoda, H
    Kojima, M
    Matsuo, H
    Kangawa, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (29) : 21995 - 22000
  • [20] Structural divergence of human ghrelin - Identification of multiple ghrelin-derived molecules produced by post-translational processing
    Hosoda, H
    Kojima, M
    Mizushima, T
    Shimizu, S
    Kangawa, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (01) : 64 - 70